These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 508557)

  • 1. Probenecid: an unexplained effect on cephalosporin pharmacology.
    Welling PG; Dean S; Selen A; Kendall MJ; Wise R
    Br J Clin Pharmacol; 1979 Nov; 8(5):491-5. PubMed ID: 508557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cephradine given intravenously with and without probenecid.
    Roberts DH; Kendall MJ; Jack DB; Welling PG
    Br J Clin Pharmacol; 1981 Jun; 11(6):561-4. PubMed ID: 7272172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
    Welling PG; Dean S; Selen A; Kendall MJ; Wise R
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):397-400. PubMed ID: 500261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of probenecid on the blood levels and urinary excretion of cefamandole.
    Griffith RS; Black HR; Brier GL; Wolny JD
    Antimicrob Agents Chemother; 1977 May; 11(5):809-12. PubMed ID: 879735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probenecid and the antibacterial activity of cephradine in vivo.
    Kunst MW; Mattie H
    J Infect Dis; 1978 Jun; 137(6):830-4. PubMed ID: 351091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of probenecid and food on the bioavailability of cephradine in normal male subjects.
    Mischler TW; Sugerman AA; Willard DA; Brannick LJ; Neiss ES
    J Clin Pharmacol; 1974; 14(11-12):604-11. PubMed ID: 4436447
    [No Abstract]   [Full Text] [Related]  

  • 7. Cephalosporin-probenecid drug interactions.
    Brown GR
    Clin Pharmacokinet; 1993 Apr; 24(4):289-300. PubMed ID: 8491057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. III. Investigations of the mechanism of renal elimination.
    Ungethüm W; Pabst J; Dingeldein E; Leopold G
    Arzneimittelforschung; 1979; 29(2a):443-8. PubMed ID: 582723
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of cefaclor and cephradine in serum by ion-pair reversed-phase chromatography.
    Lindgren K
    J Chromatogr; 1987 Jan; 413():351-4. PubMed ID: 3558691
    [No Abstract]   [Full Text] [Related]  

  • 10. High-pressure liquid chromatography and microbiological assay in the determination of serum levels using cefradine and cefaclor.
    Ullmann U
    Zentralbl Bakteriol A; 1980; 248(3):414-21. PubMed ID: 6784388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of five oral cephalosporins in calves.
    Soback S; Ziv G; Kurtz B; Paz R
    Res Vet Sci; 1987 Sep; 43(2):166-72. PubMed ID: 3317582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probenecid on the pharmacokinetics of moxalactam.
    DeSante KA; Israel KS; Brier GL; Wolny JD; Hatcher BL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):58-61. PubMed ID: 6211135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of probenecid on serum levels and urinary excretion of cinoxacin.
    Rodriguez N; Madsen PO; Welling PG
    Antimicrob Agents Chemother; 1979 Mar; 15(3):465-9. PubMed ID: 464575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic.
    Gower PE; Dash CH
    Br J Pharmacol; 1969 Nov; 37(3):738-47. PubMed ID: 5348475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.
    Reeves DS; Bullock DW; Bywater MJ; Holt HA; White LO; Thornhill DP
    Br J Clin Pharmacol; 1981 Apr; 11(4):353-9. PubMed ID: 7259928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of ceftizoxime with and without probenecid].
    Adam D; Timmler R
    Arzneimittelforschung; 1982; 32(4):416-9. PubMed ID: 6285937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of (14C) cefaclor, a cephalosporin antibiotic, in three species of laboratory animals.
    Sullivan HR; Due SL; Kau DL; Quay JF; Miller W
    Antimicrob Agents Chemother; 1976 Oct; 10(4):630-8. PubMed ID: 984800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of probenecid on the pharmacokinetics of DQ-2556, a new 3-quaternary ammonium cephalosporin antibiotic, in humans.
    Shiba K; Yoshida M; Shimada J; Saito A; Matsubayashi K; Hashimoto S; Yoshida K; Osada Y; Sakai O
    Chemotherapy; 1992; 38(6):369-75. PubMed ID: 1288960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic studies with cefaclor, a new oral cephalosporin.
    Meyers BR; Hirschman SZ; Wormser G; Gartenberg G; Srulevitch E
    J Clin Pharmacol; 1978 Apr; 18(4):174-9. PubMed ID: 632363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.